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Background: Mycobacterium abscessus causes lung infection in patients with cystic ﬁbrosis. M. abscessus stimulates the host innate immune
response via TLR2 on respiratory epithelial cells. Signaling through TLR2 requires the formation of TLR2/TLR1 heterodimers on the cell surface.
Methods: The ability of M. abscessus to stimulate the innate immune response of cystic ﬁbrosis CFBE41o- respiratory epithelial cells was
measured as expression of HβD2 by RT PCR, and release of IL-8 by ELISA. Genotyping of CFBE41o- TLR polymorphisms was carried out.
Results: CFBE41o- cells are hyporesponsive to M. abscessus. They are homozygous for the TLR1 SNP I602S which has been demonstrated to
cause diminished cellular responses to TLR2 agonists.
Conclusions: Homozygosity for I602S is prevalent in Western Europeans and North American Caucasians, the same demographic in which the
ΔF508 mutation is present. This SNP may play a role in the pathogenesis of M. abscessus lung infection in patients with cystic ﬁbrosis.
Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.1. Introduction
The CFBE41o- respiratory epithelial cell line was derived
from the bronchus of a patient with cystic fibrosis and
immortalized with SV40 [1,2]. We have found that this cell line
fails to generate an innate immune response to M. abscessus, a
pathogen causing progressive lung disease in patients with cystic
fibrosis.
Respiratory epithelium has been increasingly recognized as
playing an important role in the innate immune response to
pulmonary pathogens. These cells are among the various cell
types which express toll-like receptors (TLRs); receptors which
mediate the innate immune response to invading pathogens [3].
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http://dx.doi.org/10.1016/j.jcf.2013.01.001expressed by respiratory epithelial cells in response to TLR
stimulation [4–6].
M. abscessus exists as either a glycopeptidolipid (GPL)
expressing variant (smooth phenotype) in which GPL masks
underlying bioactive cell wall lipids, or as a variant lacking GPL
(rough phenotype) which is immunostimulatory and invasive in
macrophage infection models [7–9]. We have demonstrated that
the rough phenotype stimulates host cell innate immune responses
via TLR2 [6,8,9]. Importantly, it has been demonstrated that
optimal mycobacterial TLR2 signaling involves formation of
heterodimers with TLR1 at the cell surface [10,11]. Recent studies
indicate that a single nucleotide polymorphism (SNP) in the TLR1
gene at 1805T/G (rs5743618) i.e., Ile602Ser (isoleucine to serine,
non-synonymous polymorphism) (I602S), confers impaired
function on TLR1 [12,13]. This SNP is common in the Caucasian
population of Western Europe and in Caucasians of European
descent in the United States and Canada [14]. This is the same
demographic in which the cystic fibrosis CFTR ΔF508 mutation
occurs. In our study, we demonstrate hyporesponsiveness of
CFBE41o- cells to M. abscessus and Pam3Cys, another TLR2ystic Fibrosis Society.
774 P. Kempaiah et al. / Journal of Cystic Fibrosis 12 (2013) 773–779ligand. Importantly, we demonstrate that CFBE41o- cells are
homozygous for TLR1 SNP I602S.
2. Materials and methods
2.1. Bacteria
The isogenicM. abscessus 390S (smooth colony morphotype
expressing GPL), 390R and 390V (rough colony morphotype
lacking GPL expression) variants have been previously charac-
terized [15]. Bacteria were cultured and stored at −70 °C as
described [7].
2.2. Cell lines
The CFBE41o-, CFBE41o-/CEP-CFTR, CFTE29o- and
16HBE14o- respiratory epithelial cell lines were obtained from
Dr. Dieter Gruenert at the University of California San Francisco
with origins as described [1,2,16–18]. Upon receipt, CFBE41o-
cells were passage 4.80, CFBE41o-/CEP-CFTR cells were
passage 4.77.96, CFTE29o- cells were passage 2.49, and
16HBE14o- cells were passage 2.51. The CFBE41o- cell line
has been extensively characterized and used in numerous studies
examining how the CFTR ΔF508 mutation affects the normal
functions of respiratory epithelium. Importantly, this cell line
remains homozygous for CFTR ΔF508 over multiple passages
in culture [2]. Upon receipt, cells were passaged 3 times,
cryopreserved and stored in multiple vials. For each set of
experiments, a new vial was thawed and cells passaged not more
than 5 times. Cells were cultured in a T-75 tissue culture flask in
6 ml of media—MEM with 10% FBS (Invitrogen 16000–044)
and 1% Antibiotic/Antimycotic (Gibco 15240), CFBE41o-/
CEP-CFTR cells were grown in the same medium plus
hygromycin (cell culture medium). Specific additives to tissue
culture flasks were not required for growth of confluent cell
monolayers. Cells were split every 3–4 days. Confluent cell
monolayers were trypsinized with 0.5 ml 0.25% trypsin
(Invitrogen 25200056) at 37 °C. New flasks were seeded at
1:10 ratio from trypsinized confluent flasks.
2.3. Treatment of respiratory epithelial cells for measurement
of HβD2 gene expression
Respiratory cells were plated at a concentration of 1.5–2×105
cells per well in cell culture medium in 6 well tissue culture plates
and incubated at 37 °C, 5% CO2 for 72 h. After washing,
individual wells containing cell monolayers then received
1×107 cfu of the M. abcessus variant 390R. Additional wells
received MALP-2 (Imgenex IMG2206) as a control for
functioning TLR2, via stimulation of TLR2/TLR6 heterodimers,
at a final concentration of 100 ng/ml and Pam3Cys (Imgenex
IMG2201), which signals through TLR2/TLR1 heterodimers, at
concentrations ranging from 100 ng/ml to 10,000 ng/ml. IL-1β
(PeproTech 20001B) bypasses TLRs but signals through distal
common pathways leading to HβD2 gene expression. It was
added to some wells at a final concentration of 20 ng/ml as an
additional control. The negative control wells received mediaalone. All wells received their respective treatments in a final
volume of 2 ml Iscove's Modified Dulbecco's Medium +5%
NHS (Sera Care Life Sciences Human AB serum male
cc-520-100), in triplicate. Following incubation at 37 °C, 5%
CO2 for 8 h, cells were rinsed 3 times with Iscove's Modified
Dulbecco's Medium, and harvested for RNA isolation using the
RNeasy Mini Kit (Qiagen 74104).
2.4. Real-time PCR assessment of HβD2 gene expression
The HβD2 primer and probe sequences, and final reaction
concentrations, were based on previous reports and were
as follows: forward: 5′-GAGGAGGCCAAGAAGCTGC-3′
(300 nM); reverse: 5′-CGCACGTCTCTGATGAGGG-3′
(300 nM); probe: 5′-FAM-TGGCTGATGCGGATTCAGAAAG
GG-TAMRA-3′ (250 nM) [5]. The ABI Human 18S rRNA
primer/probe mix (ABI 4319413e) was used per the
manufacturer's instruction for detection of 18S. qRTPCR of the
RNA was performed using the ABI Taqman One Step RT-PCR
Master Mix Reagents kit (4309169), per manufacturer's instruc-
tion. Relative quantity was determined using the ddCT method,
using the untreated control as the calibrator sample.
2.5. Treatment of respiratory epithelial cells for measurement
of IL-8 levels in cell supernates
CFBE41o-, CFBE41o-/CEP-CFTR, and CFTE29o- respira-
tory epithelial cells were plated at a concentration of 2×105
cells per well in cell culture medium in 24 well tissue culture
plates and incubated at 37 °C, 5% CO2 for 24 h. After
washing, wells were treated with either 10,000 ng/ml Pam3Cys,
100 ng/ml MALP-2, orM. abcessus variant 390R at a density of
2.5×106 cfu/well. The negative control wells received no
treatment. All wells received their respective treatments in a
final volume of 0.5 ml Iscove's Modified Dulbecco's Medium
+5% NHS, in triplicate. Following incubation at 37 °C, 5% CO2
for 8 h, cell supernates were collected, filtered with 0.2 μm
centrifugal filters (VWR 82031-358) and frozen at −80 °C.
Supernatants were analyzed with the BD Human IL8 ELISA set
(BD555244). The remaining cells were lysed with 150 μl 1%
cetyltrimethyl ammonium bromide in 0.1 M citric acid with
0.5% napthol blue black (cetyltrimethyl ammonium bromide:
ISC 0833; citric acid: Sigma C1909; napthol blue black: Sigma
N3005). Stained nuclei from lysed cells were transferred to a
tube containing 50 μl formaldehyde. Nuclei were counted to
determine the number of cells in each monolayer and these data
were used to standardize reporting of results as IL-8 released
per 105 cells.
2.6. Genotyping TLR1 polymorphisms
The genomic region on chromsome 4 from 38,798,485–
38,798,812 (327 bp) was PCR amplified using the forward
primer-AAGTGTTAGAGGGCTGGCCTGATT and reverse
primer-TTCACCCAGAAAGAATCGTGCCCA. The PCR
conditions were: the initial denaturation step was one cycle
for 8 min at 94 °C, followed by 34 cycles at 94 °C for 30 s,
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followed by a final extension step for 7 min at 72 °C. The
resulting PCR products were purified over Microcon® centrifugal
filter devices (10,000 mwco, Millipore). The aforementioned
primer set was used to determine the presence or absence of
T1805G polymorphism using the BigDye® Terminator Cycle
Sequencing Kit in a Model 377 Sequencing System (Applied
Biosystems, Foster City, CA) at the DNA sequencing and analysis
facility (http://hsc.unm.edu/som/programs/cidi/dna.shtml). In ad-
dition, the presence of the variant allele was confirmed by
restriction fragment length polymorphism (RFLP) analysis.
Briefly, NEBcutter V2.0 was used to determine the restriction
enzyme site for the TLR1 SNP. As such, Alu1 and Pst1 were
determined to cut only samples with the TLR1 SNP, and were
used to digest PCR samples, at 37 °C for 16–24 h. Digests
were then run on a 3% agarose gel to visualize digested DNA.
Samples digested by Alu1 produced bands that were 150 bp
and 177 bp long, and samples digested by Pst1 produced bands
that were 151 bp and 176 bp long. Samples that did not carry
the TLR1 SNP were not digested, and produced an uncut
327 bp band.3. Results
3.1. CFBE41o- cells are hyporesponsive to M. abscessus 390R
and the TLR2/TLR1 agonist Pam3Cys as measured by HβD2
gene expression
We have previously verified the specificity of HβD2 as a
readout for M. abscessus TLR2 stimulation by siRNA knock-
down of TLR2 which abrogated HβD2 release in response to
M. abscessus [6]. In addition, we have reported that phosphatidylFig. 1. CFBE41o- and CFBE41o-/CEP-CFTR cells are hyporesponsive toM. abscess
CFBE41o- cell monolayers received no treatment or were treated with IL-1β, MAL
Pam3Cys (100 ng/ml) (B). After 8 h, HβD2 gene expression was quantified by real-t
in HβD2 gene expression over that of the untreated group and presented as mean
Asterisks note differences, pb0.05, t-test. In addition, CFBE41o-/CEP-CFTR cells r
(100, 1000 and 10,000 ng concentrations) for Pam3Cys 100 ng/ml and M. abscessuinositol mannosides (PIMs) are one of the M. abscessus ligands
for TLR2. Importantly, we have demonstrated thatM. abscessus
smooth expressing variants fail to elicit a TLR2 response as a
result of expression of GPL, which masks underlying PIMs
preventing their interaction with TLR2 [8]. Based on this
evidence, epidemiologic evidence [19], and clinical evidence
[20], we have proposed that M. abscessus smooth variants are
initial colonizers of the lung [6–8,21]. Spontaneous loss of GPL
leads to the rough variant which is invasive and stimulates TLR2
[6,8,9]. Signaling by mycobacterial lipopeptides (triacylated
lipopeptides) occurs predominantly through TLR2/TLR1
heterodimers [10,11]. Our results indicate that CFBE41o- cells
generate a diminished innate immune response to theM. abscessus
rough variant 390R (Fig. 1A) and the TLR2/TLR1 agonist
Pam3Cys (Fig. 1B). Furthermore, Pam3Cys at concentrations of
1000 μg/ml and 10,000 μg/ml failed to significantly increase
HβD2 expression above untreated control (data not shown). This
hyporesposiveness toM. abscessus and Pam3Cys occurred in spite
of a robust response toMALP-2, a TLR2/TLR6 agonist, and IL-1β
which signals downstream via a common final pathway indepen-
dent of the TLRs.3.2. CFBE41o- cells complemented with a plasmid containing
wild type CFTR (CFBE41o-/CEP-CFTR cells) remain
hyporesponsive to the TLR2/TLR1 agonist Pam3Cys as mea-
sured by HβD2 gene expression
Our findings raised the question of whether this lack of
response by CFBE41o- cells could be due to the fact that these
cells are homozygous for the CFTR ΔF508 mutation, the most
common genetic variant which causes cystic fibrosis [22]. We
thus examined the response to CFBE41o- cells transformed withus and the TLR2/TLR1 ligand Pam3Cys as measured by HβD2 gene expression.
P-2 and the rough M. abscessus variant 390R (A), or the TLR2/TLR1 ligand
ime PCR. The results of real-time PCR are expressed as the relative fold increase
+/−SEM of measurements from duplicate experiments performed in triplicate.
eceived the same treatment, substituting increasing concentrations of Pam3Cys
s 390R (C). Asterisks denote differences, pb0.05, t-test.
Fig. 2. CFTE29o- cells respond to M. abscessus and the TLR2/TLR1 ligand Pam3Cys as measured by HβD2 gene expression. CFTE29o- cell monolayers received
no treatment or were treated with IL-1β, MALP-2 and the rough M. abscessus variant 390R (A), or the TLR2/TLR1 ligand Pam3Cys at increasing concentrations
(100, 1000 and 10,000 ng/ml)(B). After 8 h, HβD2 gene expression was quantified by real-time PCR. The results of real-time PCR are expressed as the relative fold
increase in HβD2 gene expression over that of the untreated group and presented as mean+/−SEM of measurements from duplicate experiments performed in
triplicate. Asterisks note differences, pb0.05, t-test. In addition, 16HBE14o- cell monolayers (non-cystic fibrosis cell line) (C) received the same treatment as in
(B). Asterisks denote differences, pb0.05, t-test.
Fig. 3. CFBE41o- and CFBE41o-/CEP-CFTR cells are hyporesponsive to M. abscessus and the TLR2/TLR1 ligand Pam3Cys as measured by IL-8 release when
compared to CFTE29o- cells. CFTE29o-, CFBE41o- and CFBE41o-/CEP-CFTR cells monolayers received no treatment, or were incubated with MALP-2 (100 ng/
ml), Pam3Cys (10,000 ng/ml) or M. abscessus 390R (5.0×106/ml). After 8 h, supernates were harvested and assayed for IL-8 by ELISA. Results are IL-8 levels
corrected to 1×105 cells minus the IL-8 levels of untreated control wells and are presented as the mean+/−SEM of measurements from duplicate experiments
performed in triplicate. Asterisks note differences, pb0.05 t-test.
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cells). In spite of expressing wild type CFTR these cells failed to
respond to a range of Pam3Cys concentrations, suggesting that
hyporesponsiveness toM. abscessus is not the result of the CFTR
Δ508 mutation (Fig. 1C).
3.3. CFTE29o- and 16HBE14o- cell monolayers respond to
both Mabs 390R and the TLR2/TLR1 agonist Pam3Cys as
measured by HβD2 gene expression
Although the defect in signaling toM. abscessus and Pam3Cys
exhibited by CFBE41o- cells was not reversed by wild type CFTR,
we sought additional evidence that this defect was not specific to
cells homozygous for the ΔF508 mutation using the CFTE29o-
cell line which is also homozygous for the ΔF508 mutation.
Challenge withM. abscessus generated a response as measured by
HβD2 gene expression which was 3.3-fold above baseline
(Fig. 2A), in contrast to the complete lack of a response exhibited
by CFBE41o- cells (Fig. 1A). Furthermore, these cells responded
to Pam3Cys with a 19-fold increase over baseline at a Pam3Cys
concentration of 10,000 ng/ml (Fig. 2B) compared with a 1.4- and
1.9-fold increase over baseline at this concentration in the
CFBE41o- and CFBE41o-/CEP-CFTR cells, respectively. TheFig. 4. CFBE41o- cells are homozygous for SNP I602S whereas CFTE29o- cells pos
to PCR amplification followed by sequencing and RFLP analyses to determine the a
(shown in box using the reverse primer sequence chromatogram), whereas the CFBE
primer sequence chromatogram) (B). The PCR products were also subjected to RF
specific digestion and distinct pattern on the agarose gel electrophoresis. (C), 16HBE
digested with Pst1 and lane 2, 4 digested with Alu1 restriction enzymes) and CFBE41
6 digested with Alu1 restriction enzymes), the lane 7 loaded with low molecular wenon-cystic fibrosis bronchial epithelial cell line 16HBE14o-
manifested low level responses to all treatments (Fig. 2C). The
decreased magnitude of these responses could relate to early
reports which indicated that this cell line overexpresses wild type
CFTR [23], and recent data indicating that CFTR has a general
dampening effect on the immune response [24,25]. However, the
responses of this cell line to Pam3Cys were above those of
untreated cells, with Pam3Cys at a concentration of 10,000 ng/ml
inducing a 3-fold increase in HβD2 gene expression over baseline
(Fig. 2C).3.4. CFBE41o- cells release decreased amount of IL-8 in
response to M. abscessus and Pam3Cys compared to CFTE29o-
cells
As further confirmation of a defect in the innate immune
response of CFBE41o- cells to TLR2/TLR1 ligands, we
assessed release of IL-8 as a readout for TLR stimulation.
Consistent with our HβD2 gene expression measurements,
CFBE41o- cells and CFBE41o-/CEP-CFTR cells released
significantly reduced amounts of IL-8 in response to both
M. abscessus and Pam3Cys (Fig. 3). In contrast, CFTE29o-sess the wild type allele. The genomic DNA from both cell lines were subjected
llele and genotypes. (A), CFTE29o- cell line possesses the wild type ‘A’ allele
41o- cell line has a mutant ‘C’ allele (shown similarly in box using the reverse
LP analyses to confirm the genotype of this 1805T/G SNP based on the allele
14o- and CFTE29o- cell lines are homozygous wild type (AA or TT, lane 1, 3
o- cell line is homozygous mutant (CC or GG, lane 5 digested with Pst1 and lane
ight ladder (NEB N3233S) to facilitate the band identification.
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Pam3Cys and M. abscessus 390R (Fig. 3).
3.5. CFBE41o- cells are homozygous for the TLR1 SNP I602S,
whereas CFTE29o- cells and 16HBE14o- cells possess wild
type TLR1
Since CFBE41o- cells respond to the TLR2/TLR6 ligand
MALP-2 this suggests that the TLR2 receptor is functional in
these cells. Conversely, the lack of response of CFBE41o- cells to
M. abscessus and the TLR2/TLR1 ligand, Pam3Cys, suggests a
problem with the TLR1 receptor in the TLR signaling pathway of
these cells. Recent studies have documented an extremely high
prevalence of the SNP TLR1 I602S which alters a specific region
of the TLR1 molecule such that it is unable to traffic to the cell
membrane and participate in TLR2/TLR1 heterodimer formation
[14]. It has been conclusively demonstrated that this SNP results
in suboptimal TLR2 signaling in response to mycobacterial
lipopeptides [12,13]. We found that CFTE29o- cells and
16HBE14o- cells have wild type TLR1 at the 1805T/G locus
(Fig. 4A, C), whereas CFBE41o- has the I602S SNP at this locus
(Fig. 4B, C). In addition, we demonstrated that CFBE41o- cells
are homozygous for this allele (Fig. 4C).
4. Discussion
Patients with cystic fibrosis are susceptible to lung infection
with NTM; the most common species being M. avium and
M. abscessus [26,27]. Susceptibility is felt to be due in part
to inspissated pulmonary secretions and resultant decreased
mucociliary clearance. This enables bacterial pathogens to
colonize the airways and invade the lung parenchyma. The
results of our study demonstrate another mechanism which may
contribute to the susceptibility of cystic fibrosis patients to lung
infection with M. abscessus and perhaps other NTM; homozy-
gosity for the TLR1 1602S SNP prevents an important
component of the host cell innate immune sensing mechanism
from recognizing this pathogen.
Our study demonstrates that the CFBE41o- cell line generates
a diminished innate immune response to M. abscessus. The
innate immune system recognizes bacteria through TLRs. TLRs
are present in alveolar macrophages, dendritic cells and mucosal
epithelial cells in the lung. TLRs recognize pathogen-associated
molecular patterns, which are conserved motifs expressed
by microorganisms, but not by higher eukaryotes [3]. TLRs
cooperate in binding ligands which initiate innate immune
signaling; the TLR2/TLR1 heterodimer is required for signaling
in response to triacylated lipopeptides found in virulent
mycobacteria and gram negative bacteria, while the TLR2/
TLR6 heterodimer is required for signaling in response to
diacylated lipopeptides found in gram positive bacteria and
mycoplasma species [10,11]. Engagement of TLRs on respira-
tory epithelial cells leads to expression of the chemokines IL-8
and MCP-1, which are involved in recruitment of circulating
neutrophils and monocytes to sites of infection/inflammation in
the lung, and expression of the human β-defensin family of
antimicrobial peptides [4–6].Respiratory epithelial cells have been increasingly recognized
as playing an important sentinel role in innate immune
recognition of respiratory pathogens. We have recently demon-
strated that respiratory epithelial cells respond to M. abscessus
rough variants with HβD2 gene expression and release of IL-8.
Furthermore, we demonstrated that TLR2 is necessary for this
interaction to occur. Conversely, M. abscessus expressing GPL
does not stimulate expression of IL-8 or HβD2 by respiratory
epithelial cells which is consistent with “masking” of underlying
bioactive cell wall lipids by GPL [6]. Because GPL-expressing
smooth variants are the predominant phenotype existing in the
environment [19], this provides an explanation whereby initial
M. abscessus colonization of abnormal lung airways escapes
detection by the innate immune system. Whereas the interaction
ofM. abscessus with TLR2/TLR1 heterodimers is influenced by
GPL expression, there is also evidence that host variation, as
manifested by SNPs in TLR genes, plays a critical role in the
outcome of mycobacterial infections. The SNP, I602S, is a
nonsynonymous polymorphism which results in defective TLR1
trafficking to the cell membrane. This results in an inability of
TLR1 to participate in heterodimer formation with TLR2, and
suboptimal signaling in response to mycobacterial lipopeptides
[13]. The clinical relevance of this SNP is underscored by the
finding that it is strongly associated with protection against the
development of leprosy, and there is evidence that selection
pressure as a result ofMycobacterium leprae infection resulted in
the emergence of this SNP in the ancestral European population.
Remarkably, 40% of European Caucasians have been found to be
homozygous for this SNP, with American and Canadian
Caucasians in the range of 60–70% for homozygosity [14]. The
mechanism by which defective TLR1 signaling in response to
M. leprae leads to protection against leprosy has not yet been
elucidated [12,14]. Although hypotheses for this effect have been
proposed, the protective effect against leprosy is counterintuitive.
One might predict that loss of function of TLR1 would lead to a
diminished protective effect rather than the reverse. This is an
unresolved paradox and may relate to the immunologic
complexity of the host-pathogen interplay that occurs in patients
with leprosy. We speculate that this loss of function may have a
significant impact on susceptibility to infection with other
mycobacteria as well. Importantly, CF is an autosomal recessive
inherited disorder characterized by mutations in the gene
encoding the CFTR protein. Of relevance to our findings is the
fact that it is one of the most common lethal hereditary disorders
among Caucasians of European descent. The most frequent
mutation in CF is a deletion of phenylalanine at position 508 of
the CFTR protein, the ΔF508 mutation [22], which is present in
CFBE41o- cells [1]. Given the fact that both CFTR ΔF508 and
TLR1 SNP I602S occur in the same demographic, this
association may be an additional factor predisposing cystic
fibrosis patients to lung airway infection, in particular, airway
infection with NTM such as M. abscessus and M. avium.
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